NCT01178047 Multicenter Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's Disease Status TERMINATED Phase PHASE4
NCT01176240 A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease Status COMPLETED Phase PHASE3
NCT01174810 Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study Status UNKNOWN Phase PHASE2
NCT01174758 Development of an Instrumented System to Measure Mobility in Parkinson's Disease Status COMPLETED Phase N/A
NCT01172379 A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With "Wearing Off" Motor Fluctuations and "On" Period Dyskinesias Status COMPLETED Phase PHASE2
NCT01171313 A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects Status COMPLETED Phase PHASE2
NCT01169324 Effect of Deep Brain Stimulation (DBS) on Sleep Architecture in Patients With Movement Disorders Status COMPLETED Phase NA
NCT01168596 Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease Status COMPLETED Phase PHASE4
NCT01167608 Barriers to Mental Healthcare Utilization in Parkinson's Disease Status COMPLETED Phase N/A
NCT01162226 Computer-Based Balance Training for People With Parkinson's Disease Status COMPLETED Phase PHASE2
NCT01155492 Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's Disease Status COMPLETED Phase N/A
NCT01151111 Relaxation Guided Imagery for Treatment of Parkinson's Disease Status COMPLETED Phase EARLY_PHASE1
NCT01149811 A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson's Disease Status COMPLETED Phase N/A
NCT01140841 A Study of Safety and Tolerability of Fipamezole in Adult Subjects With Parkinson's Disease Who Are Receiving Levodopa Status COMPLETED Phase N/A
NCT01130493 A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066 Status COMPLETED Phase PHASE3
NCT01114321 Glucose Tolerance in Patients With an Idiopathic Parkinson's Disease Status UNKNOWN Phase NA